MCW #1366
David Bick, MD Thomas Ellis, PhD
Allogeneic hematopoietic stem cell transplant (HSCT) often involves selecting from a group of siblings the best HLA match for a patient. HSCT donors must have a tissue HLA type that matches the recipient. Matching is performed on the basis of variability at three or more loci of the HLA gene, and a perfect match at these loci is preferred. High resolution typing techniques are often used to identify the best possible donor among a group of siblings. However it is expensive and time-consuming to “high-resolution type” all possible sibling donors. Here we describe a novel method for screening HLA-related siblings for HSCT.
Utilizing embryo genetic screening technology developed at the Medical College of Wisconsin, researchers at the Blood Center of Wisconsin have developed an assay using short tandem repeat (STR) linkage analysis to provide rapid and inexpensive method for screening for HLA-matched sibling donors in HSCT. The method uses linkage patterns of 6 polymorphic trimeric STRs located throughout the HLA complex. These 6 STRs were selected from over 200 known and newly identified STRs based on their chromosomal locations, polymorphism, and suitability for multiplex PCR amplification. The method involves initial duplex STR-specific amplification with fluorochrome-conjugated primers, followed by size analysis using capillary electrophoresis (ABI 3130). Comparison of STR analysis with HLA haplotypes in 26 family case workups showed 100% agreement. In 2 cases, HLA phenotypically-identical siblings were disparate at the STR locus centromeric to HLA-DPB1. This was due to a single mismatch at HLA-DP in one case and a class II crossover event in the second case. STR linkage analysis successfully identified all siblings who were HLA disparate. Analysis of 10 HLA-identical unrelated recipient/donor pairs gave no indication that STR alleles are conserved with specific HLA haplotypes. STR linkage analysis provides a rapid and inexpensive method for HLA screening of potential donors for related HCST, so that confirmatory HLA typing is performed only on likely matches. The method may be used to confirm genotypic identity in families with multiple common HLA haplotypes or homozygosity, without resorting to confirmation by sequencing may be useful for defining genetic heterogeneity within HLA haplotypes.
Validated assay
Home | About Us | Technologies | For Inventors | For Industry | Forms | Contact Us | Get Tech Alerts
Office of Technology Development MEDICAL COLLEGE OF WISCONSIN 8701 Watertown Plank Road Milwaukee, WI 53226
Patent Status: Patent Pending
Molecule Type: Biomarker
Patent Coverage Type: Method of Use
Geographical Coverage: US Patent
Related Areas of Interest: Cancer
Therapeutics
Diagnostics
Diagnostic Imaging
Medical Devices
Antibodies
Research Tools
Main Office Phone: 414-955-4362 Main Office Fax: 414-955-6619
Joseph Hill, PhD Vice President Office of Technology Development 414-955-4381 jhill@mcw.edu
Kalpa Vithalani, PhD Intellectual Property Manager Office of Technology Development 414-955-4884 kvithalani@mcw.edu